Skip to main content

Table 5 Association between clinical and treatment data and health-related quality of life and oral health-related quality of life in patients survivors of oral cancer (n = 142)

From: Oral and general health-related quality of life in patients treated for oral cancer compared to control group

Variable PCS a MCS b OHIP-14 c OIDP d
Mean ± de Mean ± de Mean ± de Mean ± de
Location     
Oral 47.5 ± 11.6 36.9 ± 9.0 18.3 ± 11.9 22.1 ± 18.0
Oropharynx 46.5 ± 10.5 35.4 ± 9.0 23.7 ± 9.8 28.7 ± 20.3
p e = 0.730 p e = 0.520 p g = 0.043 p g = 0.155
Clinical stage     
I-II 49.1 ± 11.9 36.5 ± 10.0 14.8 ± 10.3 17.0 ± 15.7
III-IV 46.2 ± 11.0 36.1 ± 8.1 22.0 ± 11.9 27.4 ± 19.0
p e = 0.133 p e = 0.768 p g = <0.001 p g = <0.001
Follow-up (years)     
0.5-5 41.5 ± 1.3 46.0 ± 1.2 19.5 ± 1.3 23.4 ± 1.9
6-10 43.5 ± 2.1 44.7 ± 2.3 16.5 ± 1.7 20.1 ± 2.7
11-20 43.7 ± 2.8 47.0 ± 2.2 20.8 ± 3.2 25.6 ± 5.8
p f = 0.614 p f = 0.780 p h = 0.454 p h = 0.743
Treatment     
Surgery 47.5 ± 12.1 36.7 ± 9.6 16.1 ± 11.6 19.0 ± 18.4
Combined treatment 47.3 ± 10.8 36.8 ± 8.2 22.0 ± 11.3 26.7 ± 17.6
p e = 0.897 p e = 0.950 p g = 0.002 p g = 0.002
  1. aPCS: Physical Component Summary; bMCS: Mental Component Summary; cOHIP-14: Oral Health Impact Profile; dOIDP: Oral Impacts on Daily Performances; eStudent’s t test; fANOVA test; gMann–Whitney U test; hKruskal Wallis test.